StreetAccount Summary - Trading higher/lower: EU mid-morning
RBC Capital Markets upgrades DIM.FP, SRT3.GR
CORRECTION: Sartorius Stedim Biotech upgraded to buy from neutral at CIC Market Solutions (€190.45, 0.00)
Sartorius Stedim Biotech reports preliminary H1 revenue €1.49B vs prior guidance €1.40B (€190.45, 0.00)
Sartorius Stedim Biotech Chairman Joachim Kreuzburg resigns; Michael Grosse appointed as successor (€197.05, 0.00)
BNP Paribas Exane reinitiates DIM.FP, SRT3.GR
Sartorius Stedim Biotech downgraded to sector perform from outperform at RBC Capital Markets (€200.00, 0.00)
Powered by FactSet Research Systems Inc.